Published Articles

  1. Hearing loss prevalence and years lived with disability, 1990–2019: findings from the Global Burden of Disease Study 2019. Lancet 2021; 397: 996–1009. https://doi.org/10.1016/S0140-6736(21)00516-X
  2. Mapping routine measles vaccination in low- and middle-income countries. Nature . 2021 Jan;589(7842):415-419. doi: 10.1038/s41586-020-03043-4https://pubmed.ncbi.nlm.nih.gov/33328634/
  3. Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000–17. Lancet Glob Health 2020; 8: e1038–60. DOI:https://doi.org/10.1016/S2214-109X(20)30230-8https://www.thelancet.com/action/showPdf?pii=S2214-109X%2820%2930230-8 
  4. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396: 1204–22. https://doi.org/10.1016/S0140-6736(20)30925-9https://bbibliograficas.ucc.edu.co:2152/science/article/pii/S0140673620309259?via%3Dihub 
  5. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396: 1160–203. DOI:https://doi.org/10.1016/S0140-6736(20)30977-6https://www.thelancet.com/action/showPdf?pii=S0140-6736%2820%2930977-6
  6. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396: 1223–49DOI:https://doi.org/10.1016/S0140-6736(20)30752-2https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30752-2/fulltext 
  7. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396: 1250–84. https://doi.org/10.1016/ S0140-6736(20)30750-9https://www.thelancet.com/action/showPdf?pii=S0140-6736%2820%2930750-9 
  8. Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017. Nature Medicine | VOL 26 | May 750 2020 | 750–759https://doi.org/10.1038/s41591-020-0807-6https://www.nature.com/articles/s41591-020-0807-6 
  9. Five insights from the Global Burden of Disease Study 2019. Lancet 2020; 396: 1135–59https://doi.org/10.1016/S0140-6736(20)31404-5https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7116361/pdf/EMS103698.pdf 
  10. Mapping geographical inequalities in access to drinking water and sanitation facilities in low-income and middle-income countries, 2000–17. Lancet Glob Health 2020; 8: e1162–85. https://doi.org/10.1016/S2214-109X(20)30278-3https://www.thelancet.com/action/showPdf?pii=S2214-109X%2820%2930278-3 
  11. Synchronous Early Breast Cancer and Locally Advanced Primary Bladder Adenocarcinoma. Int J Cur Res Rev | Vol 12 . Issue 10 . May 2020.  http://dx.doi.org/10.31782/IJCRR.2020.12104https://www.ijcrr.com/uploads/2681_pdf.pdf 
  12. Evaluation Of The Prognostic Level Of PSA In Patients With Prostate Cancer Undergoing Orchiectomy And Drug Therapy. International Journal of Current Medical And Pharmaceutical Research, Vol. 6, Issue, 04(A), pp. 5072-5079, April, 2020.  http://dx.doi.org/10.24327/23956429.ijcmpr202004868https://journalcmpr.com/sites/default/files/issue-files/2001-A-2020.pdf 
  13. Breast Cancer Screening Among Medical Staff in Tehran, Iran: Improvement of Early Detection. Acta Medica Iranica, Vol. 58, No. 1(2020).  https://doi.org/10.18502/acta.v58i1.3704https://acta.tums.ac.ir/index.php/acta/article/view/7990 
  14. Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000–17: analysis for the Global Burden of Disease Study 2017. The Lancet. VOLUME 395, ISSUE 10239, P1779-1801, JUNE 06, 2020. https://doi.org/10.1016/S0140-6736(20)30114-8https://www.thelancet.com/action/showPdf?pii=S0140-6736%2820%2930114-8 
  15. Patient Flow Analysis in General Hospitals: How Clinical Disciplines Affect Outpatient Wait Times. Hosp Pract Res. 2019 Dec;4(4):128-133http://www.jhpr.ir/article_99076_1fa38b763cbfb23c70e210aac28e31e0.pdf 
  16. Developing a Quality Registry Network on Colorectal Cancer Care (QRN-CRC) in Iran; report of the pilot phase. NAACCR – IACR 2019 | June 9 – 13, 2019
  17. Disease Free Survival for Non-Metastatic Colorectal Cancer Cases in Three Referral Hospitals in Iran; Interim Report of the CRC Quality Registry Network (QRN-CRC). NAACCR – IACR 2019 | June 9 – 13, 2019
  18. Lymphovascular and Perineural Invasions Are Independently Associated with Advanced Colorectal Carcinoma. Int J Cancer Manag. 2019 November; 12(11):e95540. doi: 10.5812/ijcm.95540.http://intjcancermanag.com/en/articles/95540.html
    1. Erratum : Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017, LANCET. NOV 10 2018. Volume: 392. Issue: 10159. Pages: 1923-1994. DOI: 10.1016/S0140-6736(18)32225-6

    https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(18)32225-6.pdf

     

    1. Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017, LANCET. NOV 10 2018; Volume: 392. Issue: 10159. Pages: 2091-2138. DOI: 10.1016/S0140-6736(18)32281-5

    https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(18)32281-5.pdf

      

    1. Association Between Surgical Margin Status and Local Recurrence in Iranian Patients Suffering from Colorectal Cancer,  Int J Cancer Manag. 2018 November; 11(11):e83029

    http://intjcancermanag.com/en/articles/83029.html

     

    1. Conference: 43rd ESMO Congress (ESMO) Location: Munich, GERMANY Date: OCT 19-23, 2018
      Sponsor(s): European Soc Med Oncol; Japanese Soc Med Oncol. ANNALS OF ONCOLOGY   Volume: 29   Supplement: 8   Meeting Abstract: 236P   Published: OCT 2018

    https://apps.webofknowledge.com/full_record.do?product=WOS&search_mode=GeneralSearch&qid=1&SID=E39X8j2URPkpyYgfSqm&page=1&doc=10

     

    1. The Accuracy of Sentinel Lymph Node Biopsy Following Neoadjuvant Chemotherapy in Clinically Node Positive Breast Cancer Patients: A Single Institution Experience, INTERNATIONAL JOURNAL OF CANCER MANAGEMENT. DEC 2018. Volume: 11. Issue: 12. Article Number: e83946. DOI: 10.5812/ijcm.83946

    https://neoscriber.org/cdn/serve/314ad/eb367153529d2f0e0c2716ecb9837c7ae936b30a/ijcm-11-12-83946.pdf

     

    1. Number of Lymph Nodes Assessed in Iranian Gastric Cancer patients. Basic & Clinical Cancer Research, 2018; 10(1): 12-21

     http://bccr.tums.ac.ir/index.php/bccrj/article/view/263

     

    1. Performance Assessment of Appointment System in Managing Outpatients’ Waiting Time in a General Hospital: A Case Study.  International Journal of Hospital Research 2017, 6(4): x-x

    http://ijhr.iums.ac.ir/article_90621_54e4a20182c5e1ee3f6edd5c99d727ef.pdf

     

    1. Male Adenoid Cystic Carcinoma of Breast. International Journal of Cancer Management (IJCM). 2017 September; 10(9):e7827.

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3884210/

     

    1. Prognostic Factors and Survival of Glioblastoma Multiform (GBM) in Iranian Patients. International Journal of Cancer Management (IJCM). 2017 April; 10(4):e6260

    http://ijcancerprevention.com/en/articles/6260.html

     

    1. Relationship between erb-B2 mRNA Expression in Blood and Tissue of Invasive Ductal Carcinoma Breast Cancer Patients and Clinicopathological Characteristics of the Tumors. Asian Pacific Journal of Cancer Prevention, Vol 17, 2016, PP:249- 254

    http://www.apocpcontrol.org/page/apjcp_issues_view.php?pno=8719&gubun=p&s_search=&s_paper_vol=17&s_number33=1

     

    1. Malignant Retroperitoneal Hemangiopericytoma: Report of a 73 Years Old Woman and Review of Literature. Thrita Vol. 2, Issue 2, Nov 2013 PP:80-3

         http://thritajournal.com/?page=article&article_id=10606

     

    1. The Phase 2 Study of “(TOX) Preoperative Chemotherapy” Response Rate and Side Effects in  [Locally Advanced Operable Gastric Adenocarcinoma] Patients With Docetaxel, Oxaliplatin and      Capcitabine.  ranian Journal of Cancer Prevention,  6, No. 3, Summer 2013PP: 133-140

          http://journals.sbmu.ac.ir/index.php/cp/article/view/4291

     

    1. Comparison of Artificial Neural Network and Cox Regression Models in Survival Prediction of Breast Cancer Patients. Scientific Journal of Ilam University of Medical Sciences, Vol. 22, No. 2, Spring 2013 PP:120-128

     http://www.sjimu.medilam.ac.ir/browse.php?a_code=A-10-220-

     

    1. Complete Chemotherapeutic Regression of a Non- Metastatic of Primary Pure Small Cell arcinoma

    of the Prostate.  Current Urology, An international journal for new findings in urology. Vol. 6, No. 1, 2012   May 2012 PP: 43-45

    http://content.karger.com/ProdukteDB/produkte.aspAktion=Ausgabe&Ausgabe=257165&ProduktNr=231997

     

 

 

Back

 

 

© Milad Hospital 2015